Senzar Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Senzar Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-81,600	Closed	-$5.16M	–	27
2018 Q1	$5.16M	Buy	+81,600	New	+$5.25M	1.63%	23

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Senzar Asset Management's BMY Position: Q2 2018 in Review

Senzar Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 81,600 shares — an estimated $5.16M sold.

Senzar Asset Management first reported a position in BMY in Q1 2018 and held it in 1 quarter. The position peaked at $5.16M in Q1 2018. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

Senzar Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
Senzar Asset Management sold 81,600 Bristol-Myers Squibb shares in Q2 2018, an estimated $5.16M.
Senzar Asset Management first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 1 quarter.
Senzar Asset Management's Bristol-Myers Squibb position peaked at $5.16M in Q1 2018.
1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Senzar Asset Management's 13F filing for Q2 2018, filed 13 Aug 2018.